iShares US Pharmaceuticals (IHE)
AMEX
Year End March 30 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | 0.72 | 1.402 | 4.016 | -9.98 | 29.401 | 10.055 | -8.942 | 20.006 |
Return on Equity (%) | 0.842 | 1.618 | 4.475 | -10.481 | 30.543 | 10.422 | -9.295 | 20.908 |
Return on Invested Capital (%) | 744.873 | 1651.244 | 1020.814 | 587.139 | 521.556 | 1010.578 | 1599.533 | 991.847 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | 150.968 | 147.203 | 154.046 | 134.831 | 177.381 | 194.178 | 175.423 | 67.91 |
Earnings Per Share | 1.2 | 3.38 | 6.938 | -16.911 | 48.194 | 18.922 | -16.967 | 11.164 |
Cash Per Share | N/A | N/A | N/A | 0.089 | N/A | 0.003 | 0.1 | 0.071 |
Working Capital Per Share | 0.142 | 0.155 | 0.189 | 0.581 | 0.304 | 0.296 | 0.11 | 0.148 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | 2.475 | 6.745 | 8.781 | -14.52 | 50.457 | 21.985 | -13.198 | 11.902 |
Year End March 30 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Shares Outstanding | 4.75M | 2.65M | 2.5M | 2.05M | 2M | 2.1M | 2.15M | 9.7M |
Year End March 30 2024 | ||||||||
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Shares Outstanding | N/A | |||||||
Return on Assets (%) | N/A | |||||||
Return on Equity (%) | N/A | |||||||
Return on Invested Capital (%) | N/A | |||||||
Operating Margin (%) | N/A | |||||||
Net Profit Margin (%) | N/A | |||||||
Sales Per Share | N/A | |||||||
Book Value Per Share | N/A | |||||||
Earnings Per Share | N/A | |||||||
Cash Per Share | N/A | |||||||
Working Capital Per Share | N/A | |||||||
Operating Profit Per Share | N/A | |||||||
EBIT Per Share | N/A | |||||||
EBITDA Per Share | N/A | |||||||
Free Cash Flow Per Share | N/A | |||||||
Current Ratio | N/A | |||||||
Quick Ratio | N/A | |||||||
Inventory Turnover (Days) | N/A |
Market Cap | 648.16M |
Price to Earnings Ratio | 5.94 |
Price to Sales Ratio | 63.2 |
Price to Cash Ratio | 936.58 |
Price to Book Ratio | 0.98 |
Dividend Yield | 137.11% |
Shares Outstanding | 9.7M |
Average Volume (1 week) | 95.09k |
Average Volume (1 Month) | 71.37k |
52 Week Change | 8.58% |
52 Week High | 72.94 |
52 Week Low | 61.1189 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.